John Lin

10PUBLICATIONS

70CO-AUTHORS

Pricing (incl. consumer value estimation)Cancer diagnosisSocial epidemiologyTaxation accountingCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 25, 2026

Identifying Meaningful Patient Savings on Generics: Direct-to-Consumer Prices Versus Commercial Insurance Cost Sharing.

|Mar 30, 2026

Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability.

Mohammad Jad Moussa, Alexander Y Andreev-Drakhlin, Aradhana M Venkatesan

|Sep 26, 2025

Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality.

Maureen E Canavan, Lee Cheng, Jenny Jing Xiang

|Sep 19, 2025

Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis.

Pengxiang Li, John K Lin, Matthew J Klebanoff

|Aug 27, 2025

Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers.

John K Lin, Jiangong Niu, Sharon H Giordano

|Aug 25, 2025

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Yago Nieto, John F Ward, Wayne Hofstetter

Pageof 2

Frequent Collaborators

Jalpa A Doshi

Jenny Xiang

Sharon H Giordano

Rebecca A Snyder

Matthew T Campbell

Amishi Y Shah

Dennis L Shung

Shravan Asthana

Kever A Lewis

Matthew H G Katz

Frequent Collaborators

Jalpa A Doshi

Jenny Xiang

Sharon H Giordano

Rebecca A Snyder